Fundraising FoxNovapep
San Diego, US · 1 known investors
Find your way into Novapep
Sign up to find every way you can get introduced to Novapep
- Your email: who you already know at Novapep, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Novapep team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Novapep is an Australian-US biotech company developing G10, a polypeptide agonist that mimics activated protein C signaling to reduce inflammation. The company focuses on peptide-based therapeutics for inflammatory and infectious diseases.
Founders & leadership
JG
John GriffinCo-founder
LM
Laurent MosnierCo-founder
CJ
Chris JacksonCo-founder
JH
Jay HennockCEO & Executive Director
KP
Kent PryorExecutive Director
Board
RA
Rob AntulovChairman
Investors · 1
Frequently asked questions
- What does Novapep do?
- Novapep is an Australian-US biotech company developing G10, a polypeptide agonist that mimics activated protein C signaling to reduce inflammation. The company focuses on peptide-based therapeutics for inflammatory and infectious diseases.
- Who founded Novapep?
- Novapep was founded by John Griffin, Laurent Mosnier, Chris Jackson.
- Who are Novapep's investors?
- Novapep's investors include Sydney Angels.
- Where is Novapep headquartered?
- Novapep is headquartered in San Diego, US.